title: Outcome of radical resection and postoperative radiotherapy for thyroid carcinoma showing thymus-like differentiation.
abstract: BACKGROUND
  Carcinoma showing thymus-like differentiation (CASTLE) is a rare disease that is difficult to diagnose. The aim of this study was to assess the effects of combined-modality treatment in CASTLE patients.
  
  
  METHODS
  We retrospectively studied patients identified between January 1, 2000 and December 31, 2009 as having CASTLE and who subsequently underwent surgery and radiotherapy or chemotherapy. Preoperative laboratory findings, ultrasonographic (US) and computed tomographic (CT) features, and fine-needle aspiration biopsy (FNAB) specimens were evaluated.
  
  
  RESULTS
  Seven patients with CASTLE were identified (four men, three women). The median age at initial diagnosis was 48 years (range 25-56 years). The five newly diagnosed patients were treated with curative surgery and postoperative radiotherapy, whereas two patients with recurrent disease were treated with salvage surgery plus radiotherapy or chemotherapy. All patients were disease-free at a median follow-up period of 34 months (range 12-61 months). The pattern of immunohistochemical staining was similar to that of thymic carcinoma. Specimens from all seven patients stained positively for CD5, CD117, and cytokeratin but were uniformly negative for thyroglobulin, thyroid transcription factor 1 (TTF-1), and calcitonin.
  
  
  CONCLUSIONS
  Patients with CASTLE have excellent outcomes after curative resection and postoperative radiotherapy compared with patients with anaplastic thyroid carcinoma. Even patients with local recurrent disease benefited from salvage surgery with subsequent operation and/or radiotherapy. CD5 immunohistochemical staining on FNAB samples may help identify the possible entities that are part of the differential diagnosis.
authors: Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center (FUSCC), Shanghai 200032, China.
authors: Tuanqi
authors: T
authors: Sun
authors: Zhuoying
authors: Z
authors: Wang
authors: Jian
authors: J
authors: Wang
authors: Yi
authors: Y
authors: Wu
authors: Duanshu
authors: D
authors: Li
authors: Hongmei
authors: H
authors: Ying
references: J Thorac Cardiovasc Surg. 2006 Jul;132(1):191-2
references: 16798337
references: World J Surg. 1985 Feb;9(1):128-35
references: 3984364
references: Am J Clin Pathol. 2007 Feb;127(2):230-6
references: 17210519
references: Int J Surg Pathol. 2006 Apr;14(2):171-5
references: 16703183
references: J Formos Med Assoc. 2003 Feb;102(2):109-12
references: 12709740
references: Thyroid. 2005 Dec;15(12):1383-8
references: 16405413
references: J Surg Oncol. 1988 Jul;38(3):187-92
references: 3260644
references: Eur J Surg Oncol. 2007 Feb;33(1):83-5
references: 17085008
references: Br J Surg. 2004 Feb;91(2):142-5
references: 14760659
references: Am J Surg Pathol. 2006 Aug;30(8):994-1001
references: 16861971
references: Diagn Cytopathol. 1996 Sep;15(3):224-7
references: 8955605
references: Thyroid. 2006 Feb;16(2):187-94
references: 16676409
references: Kaohsiung J Med Sci. 2008 Nov;24(11):591-7
references: 19239992
references: Pathol Int. 2008 Dec;58(12):775-9
references: 19067852
references: Histopathology. 2001 Sep;39(3):279-86
references: 11532039
references: Head Neck. 2005 Oct;27(10):927-33
references: 15952197
references: Histopathology. 1998 Feb;32(2):104-9
references: 9543665
references: Hum Pathol. 1991 Apr;22(4):349-67
references: 2050369
references: Pathology. 2006 Dec;38(6):541-4
references: 17393982
references: Mod Pathol. 1998 Oct;11(10):989-94
references: 9796728